COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acadia Pharmaceuticals Inc. | COM | 004225108 | 650,286 | 20,481,442 | SH | | SOLE | | 20,481,442 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 1,121 | 28,765 | SH | | SOLE | | 28,765 | 0 | 0 |
Achaogen Inc. | COM | 004449104 | 1,305 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Achillion | COM | 00448Q201 | 5,370 | 438,337 | SH | | SOLE | | 438,337 | 0 | 0 |
Acorda Therapeutics, Inc. | COM | 00484M106 | 30,879 | 755,534 | SH | | SOLE | | 755,534 | 0 | 0 |
Aerie Pharmaceuticals | COM | 00771V108 | 8,738 | 299,356 | SH | | SOLE | | 299,356 | 0 | 0 |
Affimed Therapeutics B.V. | COM | N01045108 | 2,480 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Agios Pharmaceuticals | COM | 00847X104 | 18,307 | 163,393 | SH | | SOLE | | 163,393 | 0 | 0 |
Alcobra Ltd. | SHS | M2239P109 | 1,081 | 289,871 | SH | | SOLE | | 289,871 | 0 | 0 |
Alder Biopharmaceutical Inc. | COM | 014339105 | 4,461 | 153,350 | SH | | SOLE | | 153,350 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 1,125 | 11,600 | SH | | SOLE | | 11,600 | 0 | 0 |
Amicus Therapeutics | COM | 03152W109 | 4,008 | 481,697 | SH | | SOLE | | 481,697 | 0 | 0 |
Anacor Pharmaceuticals | COM | 032420101 | 135,602 | 4,204,702 | SH | | SOLE | | 4,204,702 | 0 | 0 |
Aptose Biosciences, Inc. | COM | 03835T200 | 2,833 | 479,164 | SH | | SOLE | | 479,164 | 0 | 0 |
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 9,078 | 1,210,350 | SH | | SOLE | | 1,210,350 | 0 | 0 |
Array Biopharma Inc. | COM | 04269X105 | 6,782 | 1,433,797 | SH | | SOLE | | 1,433,797 | 0 | 0 |
Arrowhead Research Corp. | COM | 042797209 | 9,083 | 1,230,802 | SH | | SOLE | | 1,230,802 | 0 | 0 |
Asterias Biotherapeutics, Inc. | COM SER A | 04624N107 | 54 | 16,775 | SH | | SOLE | | 16,775 | 0 | 0 |
Aurinia Pharmaceuticals, Inc. | COM | 05156V102 | 2,599 | 727,669 | SH | | SOLE | | 727,669 | 0 | 0 |
Avanir Pharmaceuticals | COM | 05348P401 | 652,807 | 38,513,713 | SH | | SOLE | | 38,513,713 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 98,697 | 4,283,732 | SH | | SOLE | | 4,283,732 | 0 | 0 |
Biocryst Pharmaceuticals Inc. | COM | 09058V103 | 130,278 | 10,713,686 | SH | | SOLE | | 10,713,686 | 0 | 0 |
BioDelivery Sciences Intl. Inc. | COM | 09060J106 | 2,524 | 210,021 | SH | | SOLE | | 210,021 | 0 | 0 |
Biomarin Pharmaceuticals | COM | 09061G101 | 335,741 | 3,713,950 | SH | | SOLE | | 3,713,950 | 0 | 0 |
Biota Pharmaceuticals | COM | 090694100 | 2,479 | 1,106,910 | SH | | SOLE | | 1,106,910 | 0 | 0 |
Biotime Inc. Rights | COM | 09066L162 | 22 | 20,525 | SH | | SOLE | | 20,525 | 0 | 0 |
Bluebird Bio Inc. | COM | 09609G100 | 13,758 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 19,945 | 6,715,462 | SH | | SOLE | | 6,715,462 | 0 | 0 |
Celsus Therapeutics | SPONSORED ADR NE | 15119A202 | 3,235 | 673,887 | SH | | SOLE | | 673,887 | 0 | 0 |
Cerus | COM | 157085101 | 73,025 | 11,702,727 | SH | | SOLE | | 11,702,727 | 0 | 0 |
Chemocentryx Inc. | COM | 16383L106 | 342 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Chimerix | COM | 16934W106 | 6,941 | 172,414 | SH | | SOLE | | 172,414 | 0 | 0 |
Clovis Oncology | COM | 189464100 | 11,347 | 202,630 | SH | | SOLE | | 202,630 | 0 | 0 |
Concert Pharmaceuticals, Inc. | COM | 206022105 | 6,732 | 505,418 | SH | | SOLE | | 505,418 | 0 | 0 |
Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | PFD CONV EX 6% | 23254L207 | 82 | 13,253 | SH | | SOLE | | 13,253 | 0 | 0 |
Cytrx Corp. | COM | 232828509 | 3,699 | 1,350,000 | SH | | SOLE | | 1,350,000 | 0 | 0 |
DBV Technologies Inc. | SPONSORED ADR | 23306J101 | 41,201 | 1,519,229 | SH | | SOLE | | 1,519,229 | 0 | 0 |
Derma Sciences | COM | 249827502 | 32,931 | 3,537,137 | SH | | SOLE | | 3,537,137 | 0 | 0 |
Dermira | COM | 24983L104 | 1,811 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Discovery Laboratories Inc. | COM | 254668403 | 4,236 | 3,652,117 | SH | | SOLE | | 3,652,117 | 0 | 0 |
Dyax Corp. | COM | 26746E103 | 86,579 | 6,157,789 | SH | | SOLE | | 6,157,789 | 0 | 0 |
Enanta Pharmaceuticals | COM | 29251M106 | 3,832 | 75,357 | SH | | SOLE | | 75,357 | 0 | 0 |
Epizyme Inc. | COM | 29428V104 | 3,811 | 201,963 | SH | | SOLE | | 201,963 | 0 | 0 |
Five Prime Therapeutics Inc. | COM | 33830X104 | 535 | 19,823 | SH | | SOLE | | 19,823 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 7,161 | 1,021,600 | SH | | SOLE | | 1,021,600 | 0 | 0 |
Foundation Medicine Inc. | COM | 350465100 | 2,803 | 126,147 | SH | | SOLE | | 126,147 | 0 | 0 |
Genomic Health Inc. | COM | 37244C101 | 436,592 | 13,656,318 | SH | | SOLE | | 13,656,318 | 0 | 0 |
Geron Corp. | COM | 374163103 | 1,309 | 402,629 | SH | | SOLE | | 402,629 | 0 | 0 |
Gilead Sciences Inc. | COM | 375558103 | 24,141 | 256,108 | SH | | SOLE | | 256,108 | 0 | 0 |
Halozyme Therapeutics Inc. | COM | 40637H109 | 26,790 | 2,776,143 | SH | | SOLE | | 2,776,143 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 26,234 | 2,607,784 | SH | | SOLE | | 2,607,784 | 0 | 0 |
Idera Pharmaceuticals Inc. | COM | 45168K306 | 7,181 | 1,628,172 | SH | | SOLE | | 1,628,172 | 0 | 0 |
Ignyta | COM | 451731103 | 3,911 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Incyte Corp. | COM | 45337C102 | 1,085,359 | 14,845,559 | SH | | SOLE | | 14,845,559 | 0 | 0 |
Infinity Pharmaceuticals Inc. | COM | 45665G303 | 5,270 | 312,025 | SH | | SOLE | | 312,025 | 0 | 0 |
Insmed Inc. | COM | 457669307 | 17,138 | 1,107,850 | SH | | SOLE | | 1,107,850 | 0 | 0 |
Ironwood Pharmaceuticals | COM | 46333X108 | 5,303 | 346,160 | SH | | SOLE | | 346,160 | 0 | 0 |
Isis Pharmaceuticals, Inc. | COM | 464330109 | 5,946 | 96,303 | SH | | SOLE | | 96,303 | 0 | 0 |
Juno Therapeutics Inc. | COM | 48205A109 | 5,222 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Karyopharm Therapeutics | COM | 48576U106 | 3,522 | 94,095 | SH | | SOLE | | 94,095 | 0 | 0 |
Kythera Biopharmaceuticals | COM | 501570105 | 9,927 | 286,255 | SH | | SOLE | | 286,255 | 0 | 0 |
La Jolla Pharmaceuticals, Inc. | COM | 503459604 | 7,779 | 421,631 | SH | | SOLE | | 421,631 | 0 | 0 |
Ligand Pharmaceuticals | COM | 53220K504 | 3,906 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
Lipocine Inc. | COM | 53630X104 | 2,630 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Loxo Oncology Inc. | COM | 548862101 | 1,175 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Macrogenics, Inc. | COM | 556099109 | 10,938 | 311,891 | SH | | SOLE | | 311,891 | 0 | 0 |
Marinus Pharmaceuticals Inc. | COM | 56854Q101 | 2,161 | 204,476 | SH | | SOLE | | 204,476 | 0 | 0 |
Mast Therapeutics, Inc. | COM | 576314108 | 2,674 | 4,774,434 | SH | | SOLE | | 4,774,434 | 0 | 0 |
Mediwound Ltd. | ORD SHS | M68830104 | 1,499 | 225,000 | SH | | SOLE | | 225,000 | 0 | 0 |
Mirati Therapeutics Inc. | COM | 60468T105 | 44,079 | 2,380,074 | SH | | SOLE | | 2,380,074 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 12,390 | 554,590 | SH | | SOLE | | 554,590 | 0 | 0 |
Neuroderm Ltd. | ORD SHS | M74231107 | 3,510 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Novavax Inc. | COM | 670002104 | 7,255 | 1,223,362 | SH | | SOLE | | 1,223,362 | 0 | 0 |
Omeros Corp. | COM | 682143102 | 16,060 | 648,101 | SH | | SOLE | | 648,101 | 0 | 0 |
Ophthotech Corp. | COM | 683745103 | 1,650 | 36,776 | SH | | SOLE | | 36,776 | 0 | 0 |
Orasure Technologies Inc. | COM | 68554V108 | 2,379 | 234,664 | SH | | SOLE | | 234,664 | 0 | 0 |
Osiris Therapeutics Inc. | COM | 68827R108 | 8,165 | 510,606 | SH | | SOLE | | 510,606 | 0 | 0 |
Palatin Technologies Inc. | COM | 696077403 | 1,497 | 2,050,000 | SH | | SOLE | | 2,050,000 | 0 | 0 |
Pharmacyclics Inc. | COM | 716933106 | 1,116,140 | 9,129,231 | SH | | SOLE | | 9,129,231 | 0 | 0 |
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 33,640 | 4,449,797 | SH | | SOLE | | 4,449,797 | 0 | 0 |
ProQR Therapeutics NV | SHS | N71542109 | 8,668 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Proteon Therapeutics, Inc. | COM | 74371L109 | 1,798 | 172,917 | SH | | SOLE | | 172,917 | 0 | 0 |
QLT Inc. | COM | 746927102 | 6,159 | 1,535,863 | SH | | SOLE | | 1,535,863 | 0 | 0 |
Receptos Inc. | COM | 756207106 | 2,928 | 23,900 | SH | | SOLE | | 23,900 | 0 | 0 |
Repros Therapeutics | COM | 76028H209 | 19,940 | 2,000,000 | SH | | SOLE | | 2,000,000 | 0 | 0 |
Rigel Pharmaceuticals | COM | 766559603 | 1,094 | 481,972 | SH | | SOLE | | 481,972 | 0 | 0 |
Sage Therapeutics Inc. | COM | 78667J108 | 2,745 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Salix Pharmaceuticals | COM | 795435106 | 73,024 | 635,321 | SH | | SOLE | | 635,321 | 0 | 0 |
Sangamo Biosciences, Inc. | COM | 800677106 | 14,531 | 955,332 | SH | | SOLE | | 955,332 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 895,197 | 27,861,720 | SH | | SOLE | | 27,861,720 | 0 | 0 |
Stemline Therapeutics Inc. | COM | 85858C107 | 5,778 | 338,671 | SH | | SOLE | | 338,671 | 0 | 0 |
Sunesis Pharmaceuticals Inc. | COM | 867328601 | 8,160 | 3,200,000 | SH | | SOLE | | 3,200,000 | 0 | 0 |
Synageva Biopharma Corp. | COM | 87159A103 | 989,182 | 10,660,432 | SH | | SOLE | | 10,660,432 | 0 | 0 |
Synergy Pharmaceuticals | COM | 871639308 | 2,968 | 973,245 | SH | | SOLE | | 973,245 | 0 | 0 |
Synta Pharmaceuticals | COM | 87162T206 | 1,325 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Tekmira Pharmaceuticals Corp. | COM | 87911B209 | 7,335 | 484,156 | SH | | SOLE | | 484,156 | 0 | 0 |
Tesaro Inc. | COM | 881569107 | 1,161 | 31,218 | SH | | SOLE | | 31,218 | 0 | 0 |
TG Therapeutics | COM | 88322Q108 | 32,477 | 2,050,313 | SH | | SOLE | | 2,050,313 | 0 | 0 |
Threshold Pharma | COM | 885807206 | 6,855 | 2,155,516 | SH | | SOLE | | 2,155,516 | 0 | 0 |
Ultragenyx Pharmaceuticals | COM | 90400D108 | 6,582 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
UniQure B.V. | SHS | N90064101 | 454 | 30,672 | SH | | SOLE | | 30,672 | 0 | 0 |
Vanda Pharmaceuticals, Inc. | COM | 921659108 | 64,041 | 4,472,153 | SH | | SOLE | | 4,472,153 | 0 | 0 |
Versartis Inc. | COM | 92529L102 | 51,225 | 2,281,744 | SH | | SOLE | | 2,281,744 | 0 | 0 |
Xencor | COM | 98401F105 | 9,486 | 591,371 | SH | | SOLE | | 591,371 | 0 | 0 |
Xenoport | COM | 98411C100 | 60,545 | 6,903,628 | SH | | SOLE | | 6,903,628 | 0 | 0 |
Xoma Corp. | COM | 98419J107 | 60,757 | 16,924,013 | SH | | SOLE | | 16,924,013 | 0 | 0 |
Ziopharm Oncology Inc. | COM | 98973P101 | 982 | 193,640 | SH | | SOLE | | 193,640 | 0 | 0 |
Zogenix, Inc. | COM | 98978L105 | 3,220 | 2,350,400 | SH | | SOLE | | 2,350,400 | 0 | 0 |
Celladon Corp | COM | 15117E107 | 7,324 | 375,000 | SH | | SOLE | | 375,000 | 0 | 0 |
Mallinckrodt PUB LTD CO | SHS | G5785G107 | 4,621 | 46,666 | SH | | SOLE | | 46,666 | 0 | 0 |
Acorda Therapeutics Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | 69,839 | 60,900,000 | PRN | | SOLE | | 60,900,000 | 0 | 0 |
Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | 102,104 | 22,898,000 | PRN | | SOLE | | 22,898,000 | 0 | 0 |
Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | 14,715 | 12,500,000 | PRN | | SOLE | | 12,500,000 | 0 | 0 |
Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | 88,977 | 21,500,000 | PRN | | SOLE | | 21,500,000 | 0 | 0 |
Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | 336,182 | 40,446,000 | PRN | | SOLE | | 40,446,000 | 0 | 0 |
Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | 388,039 | 259,000,000 | PRN | | SOLE | | 259,000,000 | 0 | 0 |
Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | 421,613 | 274,500,000 | PRN | | SOLE | | 274,500,000 | 0 | 0 |
Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | 67,334 | 34,720,000 | PRN | | SOLE | | 34,720,000 | 0 | 0 |
Protalix Biotherapeutics, Inc. Notes 4.5% 9/15/18 | CONV BONDS | 74365AAB7 | 2,645 | 3,500,000 | PRN | | SOLE | | 3,500,000 | 0 | 0 |
Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | 542,741 | 219,440,000 | PRN | | SOLE | | 219,440,000 | 0 | 0 |
Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | 27,339 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |